Despite these animal findings, post mortem evidence indicates increased 5HT synthesis in human diabetic coma.7 We have therefore determined free fatty acids and free and total tryptophan in plasma of (a) ketoacidotic diabetics, (b) well controlled diabetics, and (c) non-diabetics. CSF tryptophan and 5HIAA were measured in groups (a) and (c) as respective indices of the availability of tryptophan to the central nervous system and of 5HT synthesis therein. Determinations also were made in plasma and CSF of the dopamine precursor tyrosine and in the CSF of the dopamine metabolite homovanillic acid (HVA).
Abnormalities of brain transmitter metabolism have been reported in the encephalopathies of advanced renal and liver disease'4 and may contribute to some of the associated neurological disturbances. Minor neurological symptoms, for example drowsiness and confusion are encountered in diabetic ketoacidosis, and irreversible coma is a rare but well recognised complication.56 The finding by Jellinger and Riederer7 of raised 5-hydroxytryptamine (5HT) and 5-hydroxyindoleacetic acid (5HIAA) concentrations postmortem in brains of patients with diabetic coma suggests that brain transmitter metabolism is altered in this condition.
Brain 5HT synthesis is influenced by plasma free tryptophan as this is a major determinant of brain tryptophan concentration8 9 and tryptophan hydroxylase, the rate limiting enzyme for the synthesis of brain 5HT is normally unsaturated with tryptophan. ' °Thus, changes of availability of tryptophan influence human brain 5HT turnover9"' Normally, most of the tryptophan in plasma is not free but is bound to albumin.12 13 Free fatty acids also bind to albumin and decrease tryptophan binding thus increasing the fraction in the free state.8 14 Therefore plasma free tryptophan and thus, brain tryptophan might be expected to increase in diabetic ketoacidosis as plasma free fatty acids are elevated.'5 16 However, although rats made diabetic with streptozotocin show the above plasma changes, '7 18 brain tryptophan concentration is either unaltered or decreased' 20 probably because of high plasma concentration of branched chain amino acids which compete with tryptophan for transport to the brain.'9 Furthermore, even when brain tryptophan decreases in these diabetic rats, 5HT synthesis remains normal '8 due to a compensatory rise of tryptophan hydroxylase activity. 20 Despite these animal findings, post mortem evidence indicates increased 5HT synthesis in human diabetic coma. 7 We have therefore determined free fatty acids and free and total tryptophan in plasma of (a) ketoacidotic diabetics, (b) well controlled diabetics, and (c) non-diabetics. CSF tryptophan and 5HIAA were measured in groups (a) and (c) as respective indices of the availability of tryptophan to the central nervous system and of 5HT synthesis therein. Determinations also were made in plasma and CSF of the dopamine precursor tyrosine and in the CSF of the dopamine metabolite homovanillic acid (HVA).
Patients and Methods
Following admission to hospital, ketoacidotic diabetics were clinically assessed and treated with intravenous fluids and insulin by conventional procedures, including soluble insulin 10 units iv, immediately followed by 5 units im per hour thereafter until blood sugar control was achieved. Intravenous rehydration therapy consisted of 0-9% Saline, Tryptophan usg/ml 0-45 0-13 (19) 0-58 + 0-09 (7)* 5HIAA ,ug/ml 0-018 0-009 (19) 0-037 0-018 (7)t Tyrosine ,ug/ml 1-79 0-49 (19) 1-95 0-53 (7) HVA iLg/ml 0-032 0-015 (16) 0-041 0-026 (6) Values given as means one SD with number of patients in brackets. Differences from control group: *p < 0-05; tp < 0-01.
AMINE PRECURSORS AND METABOLITES IN THE CSF
Results in table 3 show that lumbar CSF tryptophan and 5HIAA concentrations of ketoacidotic diabetics were higher than the values for non-diabetic subjects and that CSF tyrosine and HVA were not raised in the ketoacidotic subjects. As the ketoacidotic group were largely female (5/7) significances were also calculated for females only. Significant differences persisted (tryptophan p < 0-01, 5HIAA, p < 0-05 when compared with female Table 5 CSFlplasma ratios for tryptophan and tyrosine
Non-diabetics Ketoacidotic diabetics CSF tryptophan/plasma 0-190 + 0-029 (4) 0-146 ± 0-032 (6) free tryptophan CSF tyrosine/plasma 0-137 ± 0-027 (10) 0-150 ± 0-028 (6) tyrosine Neither of the differences between the two groups of subjects was significant. Similarity of the tryptophan ratios is substantiated by calculating them from the mean values for plasma free tryptophan (Table 1) and CSF tryptophan ( Table 3) . Ratios of 0 165 and 0-149 were obtained for the non-diabetic and ketoacidotic groups respectively. controls). Furthermore, age differences did not appear to contribute to the above biochemical abnormalities as correlations coefficients of CSF tryptophan and 5HIAA vs age for non-diabetic group were far below the level of significance. Compared to alert diabetics those patients who were comatose or drowsy (n = 3) on admission tended to have slightly higher (mean + SD) CSF tryptophan (0.64 ± 0-06 vs 0-53 ± 0-09 mg/ml) and 5HIAA (0.04 ± 0-01 vs 0-03 ± 0.02) at the time of study.
However these changes were not statistically significant though this may be partly due to the small numbers involved.
RELATIONSHIP BETWEEN PLASMA AND CSF VALUES
Results in table 5 show that CSF/plasma ratios for both free tryptophan and tyrosine were essentially normal in the ketoacidotics. None of the correla-tions within groups between plasma tryptophan (total or free) and CSF tryptophan or 5HIAA concentrations or between CSF tryptophan and 5HIAA attained significance (table 4) . However as in previous studies on non diabetic subjects' correlations between CSF tryptophan or 5HIAA and plasma free tryptophan concentrations were larger than those with plasma total tryptophan.
Discussion
The results show that the raised plasma FFA concentration which occurs in ketoacidotic but not in well controlled diabetes'5 16 leads to liberation of plasma tryptophan from albumin so that total and free tryptophan concentrations are decreased and increased respectively. The rise of plasma free tryptophan leads (as in other circumstances' 2 4 8 9 22) to increased tryptophan concentration in the central nervous system, as indicated in the present study by the elevated CSF tryptophan concentration. The brain tryptophan change appears to enhance 5HT synthesis as shown by the raised CSF concentration of the 5HT metabolite 5HIAA. These results are rather similar to earlier findings on patients with advanced renal'4 or hepatic22 encephalopathy and are consistent with necropsy data7 and (in the case of the liver findings) with many animal experiments. 2 These biochemical changes could be involved in the sensorial clouding progressing to coma which occurs in these disorders. However, altered indole metabolism is only part of the widespread metabolic disturbances they cause. It may well play a part in the altered behaviour but is hardly likely to be solely responsible for it-large increases of tryptophan intake in normal subjects only moderately impair 23 24 consciousness.
The mechanisms by which brain 5HT synthesis is increased in the three disorders have similarities but they are not identical. Thus, in ketoacidotic diabetes and hepatic encephalopathy, plasma tryptophan binding is weakened because of increased free fatty acids but in renal encephalopathy plasma free fatty acids are normal and the decreased binding of tryptophan ( Although plasma concentrations of branched chain amino acids increase in both the experimental'9 and human disease,28 recent work9 on nondiabetic subjects suggests that the influence of plasma competing amino acids on human brain aromatic amino acid concentration has probably been overemphasised in the past. The present results to some extent strengthens this possibility as ratios of CSF tryptophan to plasma free tryptophan (and of plasma tyrosine to CSF tyrosine) were almost normal in the ketoacidotic group at a time when metabolic consequences of the ketoacidosis were still apparent that is, when blood glucose and plasma free fatty acid concentrations were still raised. However, plasma branched chain amino acids were not determined and therefore a firm conclusion is not possible.
As tryptophan administration increased human CSF 5HIAA," the increased availability of tryptophan to the brain appears at least partly responsible for the elevated CSF 5HIAA values (and hence for increased brain 5HT turnover) in the ketoacidotic patients. Increased brain tryptophan may however not be entirely responsible as rats made diabetic with streptozotocin show increased brain 5HT synthesis even though brain tryptophan is not raised20 and it can be seen from table 3 that the ketoacidotic patients had a relatively more marked mean rise of CSF 5HIAA than of tryptophan.
Finally, the normal plasma and CSF tyrosine concentrations in the ketoacidotic diabetics indicate that the tryptophan changes are not merely part of some non-specific change of aromatic amino acid metabolism or disposition. Similarly, the lack of a significant increase of CSF HVA indicates that the increased 5HIAA reflects increased synthesis of 5HT in the central nervous system and is not merely due to inhibition of its egress from CSF by the mechanism which it shares with HVA. 29 The MRC is thanked for financial support to GC. The MRCI is thanked for financial support to PS.
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